Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases

Pharmacogenetics and Genomics

Volumn 15, Issue 7, 2005, Pages 493-501

  Schmuck, Erica M ^a   Board, Philip G ^a   Whitbread, Astrid K ^a   Tetlow, Natasha ^a   Cavanaugh, Juleen A ^a   Blackburn, Anneke C ^a   Masoumi, Amir ^a  

^a Biology and Environment   (Australia)

Author keywords

Alzheimer's disease; Dehydroascorbate reductase; Monomethylarsonate reductase; Omega glutathione transferase; Parkinson's disease; Polymorphism

Indexed keywords

ARSENIC; DEHYDROASCORBIC ACID REDUCTASE; ENZYME VARIANT; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA; GLUTATHIONE TRANSFERASE OMEGA 1; GLUTATHIONE TRANSFERASE OMEGA 2; MONOMETHYLARSONATE REDUCTASE; NICKEL; OXIDOREDUCTASE; THIOLTRANSFERASE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

AFFINITY CHROMATOGRAPHY; ALLELE; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; ASCORBIC ACID METABOLISM; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME STABILITY; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE DELETION; GENETIC ANALYSIS; HUMAN; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERMOSTABILITY;

ESCHERICHIA COLI;

EID: 22544482100     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000165725.81559.e3     Document Type: Article

References (35)

1. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001; 360:1-16.
2. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, et al. Regulation of JNK signaling by GSTp. EMBO J 1999; 18:1321-1334.
3. Cromer BA, Morton CJ, Board PG, Parker MW. From glutathione transferase to pore in a CLIC. Eur Biophys J 2002; 31:356-364.
4. Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK, et al. Identification, characterization and crystal structure of the Omega class glutathione transferases. J Biol Chem 2000; 275:24798-24806.
5. Rouimi P, Anglade P, Benzekri A, Costet P, Debrauwer L, Pineau T, et al. Purification and characterization of a glutathione S-transferase Omega in pig: evidence for two distinct organ-specific transcripts. Biochem J 2001; 358:257-262.
6. Girardini J, Amirante A, Zemzoumi K, Serra E. Characterization of an omega-class glutathione S-transferase from Schistosoma mansoni with glutaredoxin-like dehydroascorbate reductase and thiol transferase activities. Eur J Biochem 2002; 269:5512-5521.
7. Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG. Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 2003; 13:131-144.
8. Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, et al. Human monomethylarsonic acid (MMA (V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 2001; 14:1051-1057.
9. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, et al. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol 2003; 16:1507-1513.
10. Ishikawa T, Casini AF, Nishikimi M. Molecular cloning and functional expression of rat liver glutathione-dependent dehydroascorbate reductase. J Biol Chem 1998; 273:28708-28712.
11. Fornai F, Piaggi S, Gesi M, Saviozzi M, Lenzi P, Paparelli A, et al. Subcellular localization of a glutathione-dependent dehydroascorbate reductase within specific rat brain regions. Neuroscience 2001; 104:15-31.
12. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000; 23:209-216.
13. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004; 430:631-639.
14. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, et al. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 2003; 12:3259-3267.
15. Dulhunty A, Gage P, Curtis S, Chelvanayagam G, Board P. The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J Biol Chem 2001; 276:3319-3323.
16. Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, et al. Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem 2003; 278:16567-16578.
17. Holmgren A, Aslund F. Glutaredoxin. Meth Enzymol 1995; 252:283-292.
18. Wells WW, Xu DP, Washburn MP. Glutathione: dehydroascorbate oxidoreductases. Meth Enzymol 1995; 252:30-38.
19. Denton H, McGregor JC, Coombs GH. Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. Biochem J 2004; 381:405-412.
20. Beutler E, Mathai CK, Smith JE. Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood 1968; 31:131-150.
21. Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT. Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect 2003; 111: 1421-1427.
22. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 2000; 112-113:209-217.
23. Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergeld EK. Variability in human metabolism of arsenic. Environ Res 2003; 92:85-91.
24. Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 2001; 98:266-271.
25. Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, et al. Functional characterization of two variant human GSTO 1-1 s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 2003; 301:516-520.
26. Zakharyan RA, Aposhian HV. Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA (V) reductase. Chem Res Toxicol 1999; 12:1278-1283.
27. Wells WW, Xu DP, Yang YF, Rocque PA. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem 1990; 265:15361-15364.
28. Whitbread AK, Mellick GD, Silburn PA, Le Couteur DG, Board PG. Glutathione transferase Omega class polymorphisms in Parkinson disease. Neurology 2004; 62:1910-1911.
29. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996; 36:83-106.
30. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992; 32:804-812.
31. Fornai F, Saviozzi M, Piaggi S, Gesi M, Corsini GU, Malvaldi G, et al. Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat. Neuroscience 1999; 94:937-948.
32. Fornai F, Gesi M, Saviozzi M, Lenzi P, Piaggi S, Ferrucci M, et al. Immunohistochemical evidence and ultrastructural compartmentalization of a new antioxidant enzyme in the rat substantia nigra. J Neurocytol 2001; 30:97-105.
33. Xu DP, Washburn MP, Sun GP, Wells WW. Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes. Biochem Biophys Res Commun 1996; 221:117-121.
34. Maellaro E, Del Bello B, Sugherini L, Santucci A, Comporti M, Casini AF. Purification and characterization of glutathione-dependent dehydroascorbate reductase from rat liver. Biochem J 1994; 301: 471-476.
35. Urano J, Nakagawa T, Maki Y, Masumura T, Tanaka K, Murata N, et al. Molecular cloning and characterization of a rice dehydroascorbate reductase. FEBS Lett 2000; 466:107-111.